MYC and breast adenocarcinoma: The mouse mammary tumor virus/c-Myc model was the first transgenic breast cancer mouse model reported in 1984, in which overexpression of the Myc transcription factor in the mammary gland resulted in spontaneous mammary adenocarcinomas [135].